Bernard A. Olsen, Ph.D., is an independent consultant providing expertise in chemistry, manufacturing, and control issues to the pharmaceutical industry.  He has over 37 years of experience in drug development including 29 years at Eli Lilly where he was a Senior Research Fellow.  Specific areas of experience include control strategy development, analytical method development, method validation and transfer, HPLC, spectroscopy, impurity investigations, genotoxic impurity strategies, specification development, stability studies, drug substance physical properties, CRO direction and interactions, and regulatory filing preparation.  Dr. Olsen also has experience as an expert witness in patent litigation. Dr. Olsen received a B.S. in chemistry from Nebraska Wesleyan University and a Ph.D. in analytical chemistry from the University of Wisconsin-Madison.